Does ATEZOLIZUMAB Cause Hepatic encephalopathy? 178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Hepatic encephalopathy have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.5% of all adverse event reports for ATEZOLIZUMAB.
178
Reports of Hepatic encephalopathy with ATEZOLIZUMAB
0.5%
of all ATEZOLIZUMAB reports
50
Deaths
92
Hospitalizations
How Dangerous Is Hepatic encephalopathy From ATEZOLIZUMAB?
Of the 178 reports, 50 (28.1%) resulted in death, 92 (51.7%) required hospitalization, and 4 (2.2%) were considered life-threatening.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
SORAFENIB (169)
DACLATASVIR (165)
FUROSEMIDE (130)
Which ATEZOLIZUMAB Alternatives Have Lower Hepatic encephalopathy Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN